CYL Corporation Berhad Balance Sheet Health

Financial Health criteria checks 6/6

CYL Berhad has a total shareholder equity of MYR61.6M and total debt of MYR0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are MYR73.4M and MYR11.9M respectively. CYL Berhad's EBIT is MYR9.6M making its interest coverage ratio -47.5. It has cash and short-term investments of MYR4.5M.

Key information

Debt to equity ratio

RM 0

Debt

Interest coverage ratio	-47.5x
Cash	RM 4.45m
Equity	RM 61.57m
Total liabilities	RM 11.88m
Total assets	RM 73.45m

Recent financial health updates

No updates

Recent updates

Return Trends At CYL Corporation Berhad (KLSE:CYL) Aren't Appealing

Sep 19

Returns At CYL Corporation Berhad (KLSE:CYL) Are On The Way Up

Nov 10

Investors Will Want CYL Corporation Berhad's (KLSE:CYL) Growth In ROCE To Persist

Jun 13

It's Probably Less Likely That CYL Corporation Berhad's (KLSE:CYL) CEO Will See A Huge Pay Rise This Year

Jul 19

Returns At CYL Corporation Berhad (KLSE:CYL) Are On The Way Up

Jun 06

Should You Be Adding CYL Corporation Berhad (KLSE:CYL) To Your Watchlist Today?

May 02

Does CYL Corporation Berhad (KLSE:CYL) Have The Makings Of A Multi-Bagger?

Feb 21

Here's What We Learned About The CEO Pay At CYL Corporation Berhad (KLSE:CYL)

Dec 27

We Like These Underlying Trends At CYL Corporation Berhad (KLSE:CYL)

Nov 22

Financial Position Analysis

Short Term Liabilities: CYL's short term assets (MYR22.1M) exceed its short term liabilities (MYR6.1M).

Long Term Liabilities: CYL's short term assets (MYR22.1M) exceed its long term liabilities (MYR5.8M).

Debt to Equity History and Analysis

Debt Level: CYL is debt free.

Reducing Debt: CYL had no debt 5 years ago.

Debt Coverage: CYL has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CYL has no debt, therefore coverage of interest payments is not a concern.

CYL Corporation Berhad Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Recent updates

New major risk - Market cap size

Second quarter 2025 earnings released: EPS: RM0.003 (vs RM0 in 2Q 2024)

Return Trends At CYL Corporation Berhad (KLSE:CYL) Aren't Appealing

First quarter 2025 earnings released: RM0.001 loss per share (vs RM0.005 loss in 1Q 2024)

CYL Corporation Berhad, Annual General Meeting, Jul 18, 2024

CYL Corporation Berhad Announces the Resignation of Nurly Salmi Binti Ruhaiza as Company Secretary

New major risk - Revenue and earnings growth

CYL Corporation Berhad Announces Resignation of Kuan Hui Fang as Company Secretary

CYL Corporation Berhad Appoints Mr. Wan Kai Chee as Independent and Non Executive Member of Nomination Committee

Third quarter 2024 earnings released: RM0.007 loss per share (vs RM0.002 loss in 3Q 2023)

Returns At CYL Corporation Berhad (KLSE:CYL) Are On The Way Up

Less than half of directors are independent

CYL Corporation Berhad Announces Madam Tang Sook Kuen to Step Down as Independent Non-Executive Member of Audit Committee

Second quarter 2024 earnings released: EPS: RM0 (vs RM0.003 loss in 2Q 2023)

First quarter 2024 earnings released: RM0.005 loss per share (vs RM0.005 profit in 1Q 2023)

Investors Will Want CYL Corporation Berhad's (KLSE:CYL) Growth In ROCE To Persist

CYL Corporation Berhad, Annual General Meeting, Jul 20, 2023

Full year 2023 earnings released: RM0.002 loss per share (vs RM0.014 profit in FY 2022)

CYL Corporation Berhad Appoints Encik Abd Malik Bin A Rahman as Independent and Non Executive Member of Nomination Committee

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.024 profit in 3Q 2022)

Less than half of directors are independent

Investor sentiment improved over the past week

Returns Are Gaining Momentum At CYL Corporation Berhad (KLSE:CYL)

CYL Corporation Berhad Appoints Chen Teck Sun, Age 47, as Executive Director

Second quarter 2023 earnings released: RM0.003 loss per share (vs RM0.009 loss in 2Q 2022)

Is Now The Time To Put CYL Corporation Berhad (KLSE:CYL) On Your Watchlist?

Returns Are Gaining Momentum At CYL Corporation Berhad (KLSE:CYL)

Full year 2022 earnings released: EPS: RM0.014 (vs RM0.016 in FY 2021)

CYL Corporation Berhad, Annual General Meeting, Jul 28, 2022

Full year 2022 earnings released: EPS: RM0.014 (vs RM0.016 in FY 2021)

CYL Corporation Berhad Appoints Miss. Gan Kok Ling as Independent and Non Executive Member of Nomination Committee

Here's Why We Think CYL Corporation Berhad (KLSE:CYL) Is Well Worth Watching

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: RM0.009 loss per share (vs RM0.006 profit in 2Q 2021)

It's Probably Less Likely That CYL Corporation Berhad's (KLSE:CYL) CEO Will See A Huge Pay Rise This Year

First quarter 2022 earnings released: RM0.001 loss per share (vs RM0.004 profit in 1Q 2021)

Returns At CYL Corporation Berhad (KLSE:CYL) Are On The Way Up

Should You Be Adding CYL Corporation Berhad (KLSE:CYL) To Your Watchlist Today?

Full year 2021 earnings released: EPS RM0.016 (vs RM0.002 in FY 2020)

New 90-day high: RM0.58

Does CYL Corporation Berhad (KLSE:CYL) Have The Makings Of A Multi-Bagger?

Here's What We Learned About The CEO Pay At CYL Corporation Berhad (KLSE:CYL)

Third quarter 2021 earnings released: EPS RM0.005

CYL Corporation Berhad Appoints Mr. Chen Teck Sun as Executive Director

New 90-day high: RM0.48

We Like These Underlying Trends At CYL Corporation Berhad (KLSE:CYL)

New 90-day high - RM0.38

New 90-day high - RM0.34

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies